Ono Pharmaceutical Co. Ltd - Asset Resilience Ratio

Latest as of March 2025: 0.55%

Ono Pharmaceutical Co. Ltd (ON4) has an Asset Resilience Ratio of 0.55% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€5.81 Billion

Cash + Short-term Investments

Total Assets

€1.06 Trillion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Ono Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Ono Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€5.81 Billion	0.55%
Total Liquid Assets	€5.81 Billion	0.55%

Asset Resilience Insights

Limited Liquidity: Ono Pharmaceutical Co. Ltd maintains only 0.55% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Ono Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Ono Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
AstraZeneca PLC NASDAQ:AZN	Drug Manufacturers - General	5.03%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%
Zhejiang Zhenyuan Share Co Ltd SHE:000705	Drug Manufacturers - General	5.75%
Hunan Jingfeng Pharmaceutical SHE:000908	Drug Manufacturers - General	0.38%
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	Drug Manufacturers - General	5.37%
Zhejiang Haisen Pharmaceutical Co. Ltd. A SHE:001367	Drug Manufacturers - General	32.14%
Yifan Xinfu Pharmaceutical Co Ltd SHE:002019	Drug Manufacturers - General	0.53%

Annual Asset Resilience Ratio for Ono Pharmaceutical Co. Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Ono Pharmaceutical Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.55%	€5.81 Billion	€1.06 Trillion	-3.66pp
2024-03-31	4.21%	€38.45 Billion	€913.67 Billion	-3.51pp
2023-03-31	7.72%	€68.15 Billion	€882.44 Billion	+1.25pp
2022-03-31	6.47%	€47.86 Billion	€739.20 Billion	+0.59pp
2021-03-31	5.88%	€43.93 Billion	€746.84 Billion	+1.22pp
2020-03-31	4.66%	€31.41 Billion	€673.44 Billion	+2.91pp
2019-03-31	1.75%	€11.49 Billion	€655.06 Billion	-1.61pp
2018-03-31	3.37%	€20.50 Billion	€609.23 Billion	+0.39pp
2017-03-31	2.98%	€18.38 Billion	€617.46 Billion	-1.02pp
2016-03-31	3.99%	€21.58 Billion	€540.45 Billion	--

pp = percentage points

About Ono Pharmaceutical Co. Ltd

MU:ON4 Germany Drug Manufacturers - General

Market Cap

$7.29 Billion

€6.24 Billion EUR

Market Cap Rank

#2825 Global

#470 in Germany

Share Price

€13.27

Change (1 day)

+2.12%

52-Week Range

€8.95 - €14.60

All Time High

€714354.46